References
- American Diabetes Association. (2016). Standards of medical care in diabetes: 2016. Diabetes Care, 39(Suppl. 1), S1–S112.
- American Pharmacists Association. (2016). APhA-ASP operation diabetes. Retrieved from https://www.pharmacist.com/apha-asp-operation-diabetes
- Boyle, J., Thompson, T., Gregg, E., Barker, L., & Williamson, D. (2010). Projection of the year 2050 burden of diabetes in the US adult population: Dynamic modeling of incidence, mortality and prediabetes prevalence. Population Health Metrics, 8, 29. doi:10.1186/1478-7954-8-29
- Centers for Disease Control and Prevention. (2016a). CDC prediabetes screening test. Retrieved from http://www.cdc.gov/diabetes/prevention/pdf/prediabetestest.pdf
- Centers for Disease Control and Prevention. (2016b). Prediabetes. Retrieved from http://www.cdc.gov/diabetes/basics/prediabetes.html
- Genco, R., Schifferle, R., Dunford, R., Falkner, K., Hsu, W., & Balukjian, J. (2014). Screening for diabetes mellitus in dental practices. A field trial. Journal of the American Dental Association, 145, 57–64. doi:10.14219/jada.2013.7
- Morello, C., Neighbors, M., Luu, L., Kobayashi, S., Mutrux, B., & Best, B. (2013). Impact of a first-year student pharmacist diabetes self-care education program. American Journal of Pharmaceutical Education, 77, 215. doi:10.5688/ajpe7710215
- Portero Mclellan, K., Wyne, K., Villagomez, E., & Hsueh, W. (2015). Therapeutic interventions to reduce the risk of progression from prediabetes to type 2 diabetes mellitus. Therapeutics and Clinical Risk Management, 10, 173–188.
- Zhang, Y., Dall, T., Chen, Y., & Quick, W. (2009). Medical cost associated with prediabetes. Population Health Management, 12, 157–163. doi:10.1089/pop.2009.12302